HL7 Terminology (THO)
3.0.0 - Publication
This page is part of the HL7 Terminology (v3.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "CodeSystem",
"id" : "ca-hc-din",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system http://hl7.org/fhir/NamingSystem/ca-hc-din defines many codes, but they are not represented here</p></div>"
},
"url" : "http://hl7.org/fhir/NamingSystem/ca-hc-din",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.5.1105"
}
],
"version" : "4.0.0",
"name" : "HcDIN",
"title" : "Health Canada Drug Id Number",
"status" : "active",
"experimental" : false,
"date" : "2021-10-04T00:00:00-04:00",
"publisher" : "Health Canada",
"contact" : [
{
"name" : "Health Canada,Health Canada"
}
],
"description" : "A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics:\r\n\r\n * manufacturer\r\n * product name\r\n * active ingredient(s)\r\n * strength(s) of active ingredient(s)\r\n * pharmaceutical form, and\r\n * route of administration.\r\n\r\nNote: The number has a leading zero.\r\n\r\nFurther information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html",
"content" : "not-present"
}